Fibroblast Growth Factor 21 (FGF21) Attenuates Tacrolimus-induced Hepatic Lipid Accumulation Through Transcription Factor EB (TFEB)-regulated Lipophagy

Overview

Journal J Zhejiang Univ Sci B

Specialties Biology
General Medicine

Date 2023 Jun 13

PMID 37309040

Authors

Zhensheng Zhang

Li Xu

Xun Qiu

Xinyu Yang

Zhengxing Lian

Xuyong Wei

Di Lu

Xiao Xu

Affiliations

Soon will be listed here.

Abstract

Tacrolimus (TAC), also called FK506, is one of the classical immunosuppressants to prevent allograft rejection after liver transplantation. However, it has been proved to be associated with post-transplant hyperlipemia. The mechanism behind this is unknown, and it is urgent to explore preventive strategies for hyperlipemia after transplantation. Therefore, we established a hyperlipemia mouse model to investigate the mechanism, by injecting TAC intraperitoneally for eight weeks. After TAC treatment, the mice developed hyperlipemia (manifested as elevated triglyceride (TG) and low-density lipoprotein cholesterol (LDL-c), as well as decreased high-density lipoprotein cholesterol (HDL-c)). Accumulation of lipid droplets was observed in the liver. In addition to lipid accumulation, TAC induced inhibition of the autophagy-lysosome pathway (microtubule-associated protein 1 light chain 3β (LC3B) II/I and LC3B II/actin ratios, transcription factor EB (TFEB), protein 62 (P62), and lysosomal-associated membrane protein 1 (LAMP1)) and downregulation of fibroblast growth factor 21 (FGF21) in vivo. Overexpression of FGF21 may reverse TAC-induced TG accumulation. In this mouse model, the recombinant FGF21 protein ameliorated hepatic lipid accumulation and hyperlipemia through repair of the autophagy-lysosome pathway. We conclude that TAC downregulates FGF21 and thus exacerbates lipid accumulation by impairing the autophagy-lysosome pathway. Recombinant FGF21 protein treatment could therefore reverse TAC-caused lipid accumulation and hypertriglyceridemia by enhancing autophagy.

Citing Articles

Identification of tacrolimus-related genes in familial combined hyperlipidemia and development of a diagnostic model using bioinformatics analysis.

Xu Y, He H, Li H Heliyon. 2025; 11(3):e41705.

PMID: 39916852 PMC: 11800081. DOI: 10.1016/j.heliyon.2025.e41705.

Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma.

Chen J, Li H, Zhuo J, Lin Z, Hu Z, He C Cancer Biol Med. 2024; 21(11.

PMID: 39718153 PMC: 11667780. DOI: 10.20892/j.issn.2095-3941.2024.0267.

References

Kurosu H, Choi M, Ogawa Y, Dickson A, Goetz R, Eliseenkova A . Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem. 2007; 282(37):26687-26695. PMC: 2496965. DOI: 10.1074/jbc.M704165200. View

Liu L, Tao Z, Zheng L, Brooke J, Smith C, Liu D . FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes. Cell Death Discov. 2016; 2:16066. PMC: 5046220. DOI: 10.1038/cddiscovery.2016.66. View

Medina D . Lysosomal calcium and autophagy. Int Rev Cell Mol Biol. 2021; 362:141-170. DOI: 10.1016/bs.ircmb.2021.03.002. View

Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V . Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007; 5(6):415-25. DOI: 10.1016/j.cmet.2007.05.003. View

Dehghani S, Taghavi S, Eshraghian A, Gholami S, Imanieh M, Bordbar M . Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors. J Gastroenterol. 2007; 42(9):769-74. DOI: 10.1007/s00535-007-2092-2. View

She Q, Bao J, Wang H, Liang H, Huang W, Wu J . Fibroblast growth factor 21: A "rheostat" for metabolic regulation?. Metabolism. 2022; 130:155166. DOI: 10.1016/j.metabol.2022.155166. View

Geng L, Lam K, Xu A . The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol. 2020; 16(11):654-667. DOI: 10.1038/s41574-020-0386-0. View

Visvikis O, Ihuegbu N, Labed S, Luhachack L, Alves A, Wollenberg A . Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes. Immunity. 2014; 40(6):896-909. PMC: 4104614. DOI: 10.1016/j.immuni.2014.05.002. View

Nezich C, Wang C, Fogel A, Youle R . MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J Cell Biol. 2015; 210(3):435-50. PMC: 4523611. DOI: 10.1083/jcb.201501002. View

10.

Veroux M, Tallarita T, Corona D, DAssoro A, Gurrieri C, Veroux P . Sirolimus in solid organ transplantation: current therapies and new frontiers. Immunotherapy. 2011; 3(12):1487-97. DOI: 10.2217/imt.11.143. View

11.

Wang Y, Wang Y, Li F, Zou J, Li X, Xu M . Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells. Cells. 2022; 11(7). PMC: 8997557. DOI: 10.3390/cells11071067. View

12.

Fisher F, Maratos-Flier E . Understanding the Physiology of FGF21. Annu Rev Physiol. 2015; 78:223-41. DOI: 10.1146/annurev-physiol-021115-105339. View

13.

Choi S, Reddy P . Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol. 2014; 11(9):536-47. PMC: 4151470. DOI: 10.1038/nrclinonc.2014.102. View

14.

Ballabio A, Bonifacino J . Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2019; 21(2):101-118. DOI: 10.1038/s41580-019-0185-4. View

15.

Chen L, Wang K, Long A, Jia L, Zhang Y, Deng H . Fasting-induced hormonal regulation of lysosomal function. Cell Res. 2017; 27(6):748-763. PMC: 5518872. DOI: 10.1038/cr.2017.45. View

16.

Tao Z, Aslam H, Parke J, Sanchez M, Cheng Z . Mechanisms of autophagic responses to altered nutritional status. J Nutr Biochem. 2022; 103:108955. DOI: 10.1016/j.jnutbio.2022.108955. View

17.

Byun S, Seok S, Kim Y, Zhang Y, Yau P, Iwamori N . Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun. 2020; 11(1):807. PMC: 7010817. DOI: 10.1038/s41467-020-14384-z. View

18.

Wang S, Li H, Yuan M, Fan H, Cai Z . Role of AMPK in autophagy. Front Physiol. 2022; 13:1015500. PMC: 9732440. DOI: 10.3389/fphys.2022.1015500. View

19.

Ryan A, Heath S, Cook P . Dyslipidaemia and cardiovascular risk. BMJ. 2019; 360:k835. DOI: 10.1136/bmj.k835. View

20.

Hondares E, Iglesias R, Giralt A, Gonzalez F, Giralt M, Mampel T . Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem. 2011; 286(15):12983-90. PMC: 3075644. DOI: 10.1074/jbc.M110.215889. View